If price controls are a dumb way to bring down drug costs, what WILL work?

Conservative leaders are rallying around our 501 (c)(4) partner org’s  Most Favored Patient reform agenda. This includes the very popular and workable plan to encourage direct-to-consumer pharmaceutical sales – thus cutting out middle man expenses.

Also popular is the idea of leveraging trade negotiations to get other countries – like the UK – to pay more for brand drugs.

Finally, FDA reforms to make it faster and cheaper to bring new drugs to market, will increase access to new wonder drugs AND lower prices.

On Friday, Most Favored Patient released a letter from dozens of prominent conservatives leaders to President Trump supporting this plan of action to lower drug prices: